HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy

Clinical and Experimental Dermatology

Volumn 30, Issue 4, 2005, Pages 422-425

  Urosevic, M ^a   Kempf, W ^a   Zagrodnik, B ^a   Panizzon, R ^b   Burg, G ^a   Dummer, R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BASAL CELL CARCINOMA; CANCER IMMUNOLOGY; CLINICAL ARTICLE; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; PRIORITY JOURNAL; SKIN CARCINOMA;

CARCINOMA, BASAL CELL; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOENZYME TECHNIQUES; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 20644462789     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01790.x     Document Type: Article

References (10)

1. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146: S1-6.
2. Urosevic M, Dummer R. HLA-G in skin cancer: a wolf in sheep's clothing? Hum Immunol 2003; 64: 1073-80.
3. Urosevic M, Dummer R. HLA-G and IL-10 expression in human cancer-different stories with the same message. Semin Cancer Biol 2003; 13: 337-42.
4. Zagrodnik B, Kempf W, Seifert B et al. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer 2003; 98: 2708-14.
5. Urosevic M, Willers J, Mueller B et al. HLA-G protein upregulation in primary cutaneous lymphomas is associated with IL-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 2002; 99: 609-17.
6. Aractingi S, Kanitakis J, Euvrard S et al. Selective expression of HLA-G in malignant and premalignant skin specimens in kidney transplant recipients. Int J Cancer 2003; 106: 232-5.
7. Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma, a dermatopathological and molecular biological update. Br J Dermatol 2003; 148: 195-202.
8. Urosevic M, Maier T, Benninghoff B et al. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol 2003; 139: 1325-32.
9. de Gruijl FR. Ultraviolet radiation and tumor immunity. Methods 2002; 28: 122-9.
10. Friedman EJ. Immune modulation by ionizing radiation and its implications for cancer immunotherapy. Curr Pharm Des 2002; 8: 1765-80.